140 related articles for article (PubMed ID: 17042469)
21. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection.
Lindqvist M; Persson J; Thörn K; Harandi AM
J Immunol; 2009 May; 182(10):6435-43. PubMed ID: 19414797
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of alpha-galactosyl ceramide, a potent immunostimulatory agent.
Plettenburg O; Bodmer-Narkevitch V; Wong CH
J Org Chem; 2002 Jun; 67(13):4559-64. PubMed ID: 12076157
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of immunostimulatory alpha-C-galactosylceramide glycolipids via Sonogashira coupling, asymmetric epoxidation, and trichloroacetimidate-mediated epoxide opening.
Liu Z; Byun HS; Bittman R
Org Lett; 2010 Jul; 12(13):2974-7. PubMed ID: 20518525
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of alpha-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment.
Michieletti M; Bracci A; Compostella F; De Libero G; Mori L; Fallarini S; Lombardi G; Panza L
J Org Chem; 2008 Nov; 73(22):9192-5. PubMed ID: 18956839
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000.
Raju R; Castillo BF; Richardson SK; Thakur M; Severins R; Kronenberg M; Howell AR
Bioorg Med Chem Lett; 2009 Aug; 19(15):4122-5. PubMed ID: 19535248
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues.
Altiti AS; Ma X; Zhang L; Ban Y; Franck RW; Mootoo DR
Carbohydr Res; 2017 Apr; 443-444():73-77. PubMed ID: 28365448
[TBL] [Abstract][Full Text] [Related]
27. Total synthesis of alpha-galactosyl cerebroside.
Figueroa-Pérez S; Schmidt RR
Carbohydr Res; 2000 Sep; 328(2):95-102. PubMed ID: 11028777
[TBL] [Abstract][Full Text] [Related]
28. Concise synthesis of clarhamnoside, a novel glycosphingolipid isolated from the marine sponge Agela clathrodes.
Ding N; Li C; Liu Y; Zhang Z; Li Y
Carbohydr Res; 2007 Oct; 342(14):2003-13. PubMed ID: 17559820
[TBL] [Abstract][Full Text] [Related]
29. Immunostimulatory activities of monoglycosylated alpha-D-pyranosylceramides.
Uchimura A; Shimizu T; Morita M; Ueno H; Motoki K; Fukushima H; Natori T; Koezuka Y
Bioorg Med Chem; 1997 Dec; 5(12):2245-9. PubMed ID: 9459022
[TBL] [Abstract][Full Text] [Related]
30. The synthesis and in vivo evaluation of 2',2'-difluoro KRN7000.
Leung L; Tomassi C; Van Beneden K; Decruy T; Trappeniers M; Elewaut D; Gao Y; Elliott T; Al-Shamkhani A; Ottensmeier C; Werner JM; Williams A; Van Calenbergh S; Linclau B
ChemMedChem; 2009 Mar; 4(3):329-34. PubMed ID: 19137519
[TBL] [Abstract][Full Text] [Related]
31. Lewis Acid Induced Anomerization of Se-Glycosides. Application to Synthesis of α-Se-GalCer.
McDonagh AW; Mahon MF; Murphy PV
Org Lett; 2016 Feb; 18(3):552-5. PubMed ID: 26794638
[TBL] [Abstract][Full Text] [Related]
32. A synthetic analog of alpha-galactosylceramide induces macrophage activation via the TLR4-signaling pathways.
Hung LC; Lin CC; Hung SK; Wu BC; Jan MD; Liou SH; Fu SL
Biochem Pharmacol; 2007 Jun; 73(12):1957-70. PubMed ID: 17445776
[TBL] [Abstract][Full Text] [Related]
33. Glycolipids from sponges. 13. Clarhamnoside, the first rhamnosylated alpha-galactosylceramide from Agelas clathrodes. Improving spectral strategies for glycoconjugate structure determination.
Costantino V; Fattorusso E; Imperatore C; Mangoni A
J Org Chem; 2004 Feb; 69(4):1174-9. PubMed ID: 14961667
[TBL] [Abstract][Full Text] [Related]
34. Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.
Veldt BJ; van der Vliet HJ; von Blomberg BM; van Vlierberghe H; Gerken G; Nishi N; Hayashi K; Scheper RJ; de Knegt RJ; van den Eertwegh AJ; Janssen HL; van Nieuwkerk CM
J Hepatol; 2007 Sep; 47(3):356-65. PubMed ID: 17599630
[TBL] [Abstract][Full Text] [Related]
35. A concise synthesis of tetrahydroxy-LCB, alpha-galactosyl ceramide, and 1,4-dideoxy-1,4-imino-L-ribitol via D-allosamines as key building blocks.
Luo SY; Kulkarni SS; Chou CH; Liao WM; Hung SC
J Org Chem; 2006 Feb; 71(3):1226-9. PubMed ID: 16438541
[TBL] [Abstract][Full Text] [Related]
36. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
Tulley JM; Palmer JL; Gamelli RL; Faunce DE
Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of the tetrasaccharide residue of clarhamnoside, a novel glycosphingolipid isolated from the marine sponge Agelas clathrodes.
Ding N; Wang P; Zhang Z; Liu Y; Li Y
Carbohydr Res; 2006 Dec; 341(17):2769-76. PubMed ID: 17049498
[TBL] [Abstract][Full Text] [Related]
38. RCAI-8, 9, 18, 19, and 49-52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines.
Fuhshuku K; Hongo N; Tashiro T; Masuda Y; Nakagawa R; Seino K; Taniguchi M; Mori K
Bioorg Med Chem; 2008 Jan; 16(2):950-64. PubMed ID: 17950609
[TBL] [Abstract][Full Text] [Related]
39. [Development of KRN7000, derived from agelasphin produced by Okinawan sponge].
Natori T; Akimoto K; Motoki K; Koezuka Y; Higa T
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():63P-68P. PubMed ID: 9503408
[TBL] [Abstract][Full Text] [Related]
40. Efficient synthesis of alpha-galactosyl ceramide analogues using glycosyl iodide donors.
Du W; Gervay-Hague J
Org Lett; 2005 May; 7(10):2063-5. PubMed ID: 15876055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
